openPR Logo
Press release

In Vitro Diagnostics Market Trends, Size, Growth, Leading Companies and Industry Report 2024-2032

02-08-2024 11:54 AM CET | Health & Medicine

Press release from: IMARC Group

In Vitro Diagnostics Market Report 2024-2032

In Vitro Diagnostics Market Report 2024-2032

Global In Vitro Diagnostics Market Trends:

The In Vitro Diagnostics (IVD) market is experiencing significant growth, driven primarily by the technological advancements in diagnostics have revolutionized this sector. Innovations like enhanced molecular diagnostics, point-of-care testing, and integration of artificial intelligence have improved the accuracy and efficiency of diagnostic procedures. Moreover, the rising prevalence of chronic diseases globally, such as diabetes and cancer, necessitates monitoring and testing, fueling the demand for IVD products. Furthermore, government initiatives and increased healthcare expenditure play a pivotal role.

Governments are actively improving healthcare infrastructure and accessibility to diagnostic services, alongside funding research and development in the IVD sector.

How big is the in vitro diagnostics market?

The global in vitro diagnostics market size reached US$ 110.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 178.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.24% during 2024-2032.

Request to Get the Sample Report: https://www.imarcgroup.com/in-vitro-diagnostics-market/requestsample

Factors Affecting the Growth of the In Vitro Diagnostics Industry:  

• Technological Advancements:

The IVD market is witnessing significant growth due to advancements in technology. In addition to this, innovations in diagnostics methods, such as enhanced molecular diagnostics, next-generation sequencing, and point-of-care testing, are improving the accuracy and efficiency of tests. These advancements facilitate early and precise disease detection, leading to better patient outcomes. Besides this, the integration of artificial intelligence and machine learning in IVD systems is enabling more sophisticated data analysis, further enhancing diagnostic capabilities and personalized medicine approaches across the globe.

• Increasing Prevalence of Chronic Diseases:

The rising incidence of chronic diseases worldwide, such as diabetes, cancer, and cardiovascular diseases, is a major driver for the IVD market. Chronic diseases require ongoing monitoring and management, which increases the demand for diagnostic tests. The need for early detection and regular monitoring of these diseases to prevent complications or to manage treatment effectively is fueling the demand for advanced IVD products. Furthermore, this trend will continue as the global population ages and the prevalence of chronic diseases increases.

• Government Initiatives and Healthcare Expenditure:

Government policies and funding in healthcare play a crucial role in the growth of the IVD market. Increased healthcare expenditure, along with government initiatives to improve healthcare infrastructure and access to diagnostic services, contribute significantly to market growth. Furthermore, regulatory approvals for new diagnostic tests and support for research and development activities in the IVD sector are pivotal. These factors, combined with public health initiatives aimed at disease prevention and control, are instrumental in driving the expansion of the IVD market.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Abbott Laboratories
• Agilent Technologies Inc.
• Biomerieux SA
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd
• Fujifilm Holdings Corporation
• Illumina Inc.
• Qiagen N.V
• Quest Diagnostics
• Shimadzu Corporation
• Siemens Healthcare GmbH
• Sysmex Corporation

In Vitro Diagnostics Market Report Segmentation:

By Test Type:

• Clinical Chemistry
• Molecular Diagnostics
• Immunodiagnostics
• Hematology
• Others

Molecular diagnostics is the largest segment in In Vitro Diagnostics due to its ability to detect and analyze genetic material, making it essential for diagnosing a wide range of diseases, including genetic disorders and infectious diseases, with high accuracy.

By Product:

• Reagents and Kits
• Instruments

Reagents and kits are the largest segment as they are fundamental components used in various diagnostic tests, providing the necessary chemicals and materials required for accurate and reliable testing across different applications.

By Usability:

• Disposable IVD Devices
• Reusable IVD Devices

By usability, the market is segmented into disposable IVD devices and reusable IVD devices.

By Application:

• Infectious Disease
• Diabetes
• Cancer/Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Others

Infectious diseases dominate the In Vitro Diagnostics market because of the global concern regarding infectious outbreaks.

By End User:

• Hospitals Laboratories
• Clinical Laboratories
• Point-of-care Testing Centers
• Academic Institutes
• Patients
• Others

By end user, the market is categorized into hospitals laboratories, clinical laboratories, point-of-care testing centers, academic institutes, patients, and others.

Regional Insights:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

North America's leadership in the In Vitro Diagnostics market is attributed to its advanced healthcare infrastructure, high healthcare expenditure, a strong emphasis on disease diagnosis and prevention, and a well-established market for diagnostic products and services.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=6467&flag=C

Key Highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Vitro Diagnostics Market Trends, Size, Growth, Leading Companies and Industry Report 2024-2032 here

News-ID: 3377750 • Views:

More Releases from IMARC Group

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: 5.3%
GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview Market Size in 2024: USD 266.2 Million Market Size in 2033: USD 422.9 Million Market Growth Rate 2025-2033: 5.3% According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | With a 7.50% CAGR
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview Market Size in 2024: USD 73.31 Billion Market Size in 2033: USD 147.77 Billion Market Growth Rate 2025-2033: 7.50% According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAGR
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview Market Size in 2024: USD 588.2 Million Market Size in 2033: USD 2,005.3 Million Market Growth Rate 2025-2033: 13.3% According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview: The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach

All 5 Releases


More Releases for IVD

Transformative Trends Impacting the Cancer In Vitro Diagnostics (IVD) Market Lan …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Cancer In Vitro Diagnostics (IVD) Market Size By 2025? The market size for cancer in vitro diagnostics (IVD) has seen significant growth in the past few years. The market value, which is expected to be $13.36 billion in 2024, is projected to increase to $14.32
In Vitro Diagnostics (IVD) Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this In Vitro Diagnostics (IVD) Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology. Every possible effort has been taken while researching and analysing
Companion Animal IVD Market - Guiding the Path to Optimal Health: Empowering Vet …
Newark, New Castle, USA - new report, titled Companion Animal IVD Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Companion Animal IVD market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Companion Animal IVD market. The report offers an overview of
IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The IVD research report also provides insights of different regions that are contributing market growth.
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688 The report provides a
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is